tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

PYPD Stock Latest News

PolyPid Ltd. Earnings Call: Positive Trials and Financial Strength
Company AnnouncementsPolyPid Ltd. Earnings Call: Positive Trials and Financial Strength
6d ago
PYPD
PolyPid price target lowered to $13 from $15 at Craig-Hallum
PremiumThe Fly
PolyPid price target lowered to $13 from $15 at Craig-Hallum
23d ago
PYPD
PolyPid price target raised to $10 from $9 at Roth Capital
PremiumThe Fly
PolyPid price target raised to $10 from $9 at Roth Capital
23d ago
PYPD
PolyPid Reports Strong Phase 3 Results and Financial Update
PremiumCompany Announcements
PolyPid Reports Strong Phase 3 Results and Financial Update
24d ago
PYPD
PolyPid Releases Mid-2025 Financial Update
PremiumCompany Announcements
PolyPid Releases Mid-2025 Financial Update
24d ago
6K
PYPD
PolyPid’s Promising Outlook: Buy Rating Affirmed Amidst Positive Phase 3 Results and Strategic Advancements
PremiumRatingsPolyPid’s Promising Outlook: Buy Rating Affirmed Amidst Positive Phase 3 Results and Strategic Advancements
24d ago
PYPD
PolyPid Reports Positive Phase 3 Results and Strengthens Leadership
Premium
Company Announcements
PolyPid Reports Positive Phase 3 Results and Strengthens Leadership
24d ago
6K
PYPD
PolyPid reports Q2 EPS (78c), consensus (55c)
Premium
The Fly
PolyPid reports Q2 EPS (78c), consensus (55c)
24d ago
PYPD
PolyPid sees cash runway ‘well into’ 2026
PremiumThe Fly
PolyPid sees cash runway ‘well into’ 2026
24d ago
PYPD
PolyPid Appoints New Chief Medical Officer Amid Strategic Advancements
PremiumCompany Announcements
PolyPid Appoints New Chief Medical Officer Amid Strategic Advancements
25d ago
6K
PYPD
PolyPid appoints Tweezer-Zaks as Chief Medical Officer
PremiumThe Fly
PolyPid appoints Tweezer-Zaks as Chief Medical Officer
25d ago
PYPD
PYPD Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
PYPD Upcoming Earnings Report: What to Expect?
26d ago
PYPD
PolyPid files to sell 7.63M ordinary shares for holders
PremiumThe FlyPolyPid files to sell 7.63M ordinary shares for holders
1M ago
PYPD
PolyPid Launches Long-Acting GLP-1 Delivery Platform for Diabetes Market
Premium
Company Announcements
PolyPid Launches Long-Acting GLP-1 Delivery Platform for Diabetes Market
2M ago
6K
PYPD
PolyPid Approves Key Resolutions at Annual Shareholder Meeting
Premium
Company Announcements
PolyPid Approves Key Resolutions at Annual Shareholder Meeting
2M ago
6K
PYPD
Analysts Predict Up to ~590% Spike for These 2 ‘Strong Buy’ Penny Stocks
PremiumStock Analysis & Ideas
Analysts Predict Up to ~590% Spike for These 2 ‘Strong Buy’ Penny Stocks
3M ago
PYPD
SKYE
PolyPid price target lowered to $9 from $12 at Roth Capital
PremiumThe Fly
PolyPid price target lowered to $9 from $12 at Roth Capital
3M ago
PYPD
PolyPid price target lowered to $9 from $12 at Roth Capital
PremiumThe Fly
PolyPid price target lowered to $9 from $12 at Roth Capital
3M ago
PYPD
PolyPid Secures $26.7 Million Post-Successful Phase 3 Trial
PremiumCompany Announcements
PolyPid Secures $26.7 Million Post-Successful Phase 3 Trial
3M ago
6K
PYPD
PolyPid price target lowered to $14 from $16 at Citizens JMP
PremiumThe FlyPolyPid price target lowered to $14 from $16 at Citizens JMP
3M ago
PYPD
PolyPid price target raised to $13 from $11 at H.C. Wainwright
Premium
The Fly
PolyPid price target raised to $13 from $11 at H.C. Wainwright
3M ago
PYPD
PolyPid’s D-PLEX100: Compelling Phase 3 Results and Strong Commercial Prospects Justify Buy Rating
Premium
Ratings
PolyPid’s D-PLEX100: Compelling Phase 3 Results and Strong Commercial Prospects Justify Buy Rating
3M ago
PYPD

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >